Another dengue live attenuated tetravalent vaccine (DLAV) was developed very recently and it showed a rapid increase of IFNg+TNF-α+-producing CD4+ T cells and then CD8+ T cells within 8–14 days after vaccination. The gene discussed is CD8A; the disease is dengue disease.